PPAR-γ: A nuclear receptor with affinity for cannabinoids

This publication has 44 references indexed in Scilit:

• Thiazolidinediones – some recent developments
  Expert Opinion on Investigational Drugs, 2003
• PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?
  International Journal of Obesity, 2003
• CCAAT/enhancer-binding protein β is required for mitotic clonal expansion during adipogenesis
  Proceedings of the National Academy of Sciences, 2003
• Genistein inhibits CCAAT/enhancer-binding protein β (C/EBPβ) activity and 3T3-L1 adipogenesis by increasing C/EBP homologous protein expression
  Biochemical Journal, 2002
• New drug targets for type 2 diabetes and the metabolic syndrome
  Nature, 2001
• The Effects of AICAR on Adipocyte Differentiation of 3T3-L1 Cells
  Biochemical and Biophysical Research Communications, 2001
• Inhibition of Preadipocyte Differentiation by Myostatin Treatment in 3T3-L1 Cultures
  Biochemical and Biophysical Research Communications, 2001
• A Selective Peroxisome Proliferator-Activated Receptor- (PPAR ) Modulator Blocks Adipocyte Differentiation but Stimulates Glucose Uptake in 3T3-L1 Adipocytes
  Molecular Endocrinology, 2000
• Tandem repeat of C/EBP binding sites mediates PPAR?2 gene transcription in glucocorticoid-induced adipocyte differentiation
  Journal of Cellular Biochemistry, 2000
• Thiazolidinediones Inhibit Osteoclast-Like Cell Formation and Bone Resorption in Vitro
  Endocrinology, 1999